In the lead-up to the first-ever United Nations High-Level Meeting on Tuberculosis (UN HLM), the Stop TB Partnership, Johnson & Johnson, UN Foundation, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Economic Forum will be co-hosting a TB Innovation Summit.
The event will convene a unique mix of leaders from the private and public sector, including TB survivors, academics, civil society and community leaders, donors, and technical partners, to discuss the important role that innovation can – and must – play in delivering the current tools we have today, developing the next generation of solutions we need for tomorrow, and, ultimately, driving progress toward our shared goal of ending TB.
The TB Innovation Summit will be forward-looking, uplifting, and solutions-oriented. While the task of ending TB may seem daunting, our goal is to show the world now why it is achievable if we work together in new, positive, and innovative ways. That is why the tagline for our event is "Our Journey to End TB Begins Now."
The event will also provide a platform for companies and organizations to announce new commitments for TB ahead of the UN HLM. Specifically, we anticipate announcements of new R&D funding for drugs, out-of-the-box partnerships across sectors, and new initiatives to catalyse and support current and future entrepreneurs and innovators engaged in the TB and antimicrobial resistance (AMR) space.